ORMAT TECHNOLOGIES, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ORMAT TECHNOLOGIES, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $179.38M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $158.95M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $174.90M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $192.11M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $192.44M | Feb 26, 2021 |
| FY2020 | Sep 30, 2019 | $170.50M | Feb 26, 2021 |
| FY2020 | Jun 30, 2019 | $184.07M | Feb 26, 2021 |
| FY2020 | Mar 31, 2019 | $199.04M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $190.47M | Mar 2, 2020 |
| FY2019 | Sep 30, 2018 | $166.48M | Mar 2, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $166.37M | Mar 16, 2018 |
| FY2017 | Sep 30, 2017 | $157.19M | Mar 16, 2018 |
| FY2017 | Jun 30, 2017 | $179.36M | Mar 16, 2018 |
| FY2017 | Mar 31, 2017 | $189.90M | Mar 16, 2018 |
| FY2017 | Dec 31, 2016 | $166.52M | Mar 16, 2018 |
| FY2017 | Sep 30, 2016 | $184.62M | Mar 16, 2018 |
| FY2017 | Jun 30, 2016 | $159.86M | Mar 16, 2018 |
| FY2017 | Mar 31, 2016 | $151.59M | Mar 16, 2018 |
| FY2016 | Dec 31, 2015 | $171.07M | Mar 1, 2017 |
| FY2016 | Sep 30, 2015 | $162.85M | Mar 1, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $272.69M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $272.62M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $264.02M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $268.82M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $264.34M | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $75.04M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $54.03M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $65.39M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $81.82M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $74.50M | Feb 26, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $123.90M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $123.73M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $124.40M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $65.84M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $62.09M | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $20.70M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $15.68M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $23.05M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $26.03M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $12.61M | Feb 26, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $169.23M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $172.47M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $166.59M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $152.80M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $169.36M | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $53.20M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $51.69M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $48.08M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $61.06M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $54.47M | Feb 26, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.30M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $6.50M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $7.22M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $5.08M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $4.13M | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $1.11M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $1.49M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $1.17M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $1.62M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $1.88M | Feb 26, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $335.10M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $410.92M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $309.40M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $280.97M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $258.82M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $265.01M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $236.49M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $145.82M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $245.58M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $159.29M | Mar 1, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $619.78M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $487.68M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $618.38M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $563.48M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $419.27M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $320.74M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $279.99M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $258.52M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $259.23M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $151.93M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.25B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $5.67B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $5.21B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $4.61B | Feb 23, 2024 |
| FY2023 | Dec 31, 2021 | $4.43B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $3.89B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $3.25B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $3.12B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $2.62B | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $2.46B | Mar 1, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.56B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.11B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.76B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $2.58B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $2.42B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.94B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.73B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.67B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $1.32B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.29B | Jun 19, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.54B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.43B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.32B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.87B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.85B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.81B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.39B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.32B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $1.21B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.08B | Jun 19, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $168.24M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $151.02M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $90.54M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $90.33M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $89.95M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $24.57M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $20.14M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $19.95M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $21.04M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $6.65M | Mar 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $909.34M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $814.52M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $719.89M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $623.91M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $585.21M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $550.10M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $487.87M | Feb 26, 2021 |
| FY2020 | Jan 1, 2019 | $422.16M | Feb 26, 2021 |
| FY2020 | Dec 31, 2018 | $422.22M | Feb 26, 2021 |
| FY2018 | Dec 31, 2017 | $327.26M | Mar 1, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $147.45M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $94.40M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $195.81M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $95.87M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $239.28M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $448.25M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $71.17M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $98.80M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $47.82M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $230.21M | Mar 1, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.66B | Feb 26, 2026 |
| FY2024 | Dec 31, 2024 | $2.34B | Feb 27, 2025 |
| FY2023 | Dec 31, 2023 | $1.99B | Feb 23, 2024 |
| FY2022 | Dec 31, 2022 | $2.05B | Feb 24, 2023 |
| FY2021 | Dec 31, 2021 | $1.93B | Feb 25, 2022 |
| FY2020 | Dec 31, 2020 | $1.47B | Feb 26, 2021 |
| FY2019 | Dec 31, 2019 | $1.17B | Mar 2, 2020 |
| FY2018 | Dec 31, 2018 | $1.13B | Mar 1, 2019 |
| FY2017 | Dec 31, 2017 | $877.06M | Jun 19, 2018 |
| FY2016 | Dec 31, 2016 | $956.53M | Mar 1, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 26, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 26, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 60.50M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 60.50M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 60.36M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 56.10M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 56.06M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | 55.98M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 51.03M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 50.70M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 50.61M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 49.67M | Jun 19, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.07M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $29.11M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $28.41M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $27.14M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $26.99M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $22.47M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $22.39M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $26.83M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $20.51M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $25.68M | Mar 1, 2019 |